Two novel CHD7 variants in patients with typical and mild features of CHARGE syndrome co-occurring with esophageal atresia
Devon Michael Evanovich, Anne O'Donnell-Luria, Benjamin Zendejas and 2 more
Journal of Pediatric Surgery Case Reports · 2022
doi:10.1016/j.epsc.2022.102478 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
CHARGE syndrome (Coloboma, Heart defect, Atresia of the choanae, growth Retardation, Genital abnormalities, Ear anomalies/deafness) is a rare genetic autosomal dominant disease with a prevalence of 1/10,000 live births. It is associated with pathogenic variants in the chromodomain-helicase-DNA-binding protein 7 (CHD7) gene. Although CHARGE syndrome is known to be associated with esophageal atresia (EA) and tracheoesophageal fistulas in 15–20% of cases, there are only a few clinical and molecular case descriptions of CHARGE syndrome in the context of EA. We present two individuals with novel CHD7 variants with variable clinical expression of CHARGE syndrome co-occurring with EA. Individual 1 had typical CHARGE syndrome, and a rare type D EA that required direct anastomosis repair. Genetic testing revealed a likely pathogenic essential splice site variant, c.4644+1G > T. Individual 2 had a mild CHARGE phenotype and a type A EA that required complex repair via the Foker process. The described expression of previously unreported typical CHD7 variants expands the current knowledge of CHARGE syndrome co-occurring with EA that could help with future patient care and genetic counseling. We hope that the description of the previously unreported variant of uncertain significance with a mild CHARGE phenotype will assist future classification efforts of this variant.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.